As a definite immunoprofile of this tumor is missing, the histopathologic diagnosis of intrahepatic cholangiocarcinoma is difficult. The aim of this study was to explore E- and N-cadherin ...

The Food and Drug Administration (FDA) has approved Livmarli ® (maralixibat) for the treatment of cholestatic pruritus in patients 5 years of age and older with progressive familial intrahepatic ...